Antikoagulative Strategie bei stabiler kardiovaskulärer Erkrankung
Authors:
- 4 April 2018
- journal article
- editorial
- Published by Springer Nature in Die Innere Medizin
- Vol. 59 (6) , 636-638
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysisJournal of Neurology, 2014
- Rivaroxaban in Patients with a Recent Acute Coronary SyndromeNew England Journal of Medicine, 2012
- Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994